Situation normale

ANTWERP PHARMACIES
 SRL

3800 Sint-Truiden
Since 08/08/2018
BE0700733344
Financial Health Indicator
7
Equity
€1.9M
+12% YoY
Gross Operating Margin
€602.0K
-16% YoY
EBITDA
€432.1K
-23% YoY
Gain/Loss
€193.5K
-48% YoY
Employees
2
+25% YoY

Detailed insights into ANTWERP PHARMACIES’s financial history

See financial trends including, equity, operating income, profit/loss and employees of ANTWERP PHARMACIES. Compare KPI’s against similar companies. Explore financial ratios, annual accounts and much more.

Financials 1
Financials 2
Financials 3
Financials 4
2023 2022 2021 2020 2019
Equity
1.9M
1.7M
1.3M
797.9K
267.6K
Gross Operating Margin
602.0K
719.4K
859.8K
868.9K
440.5K
Gain/Loss
193.5K
372.3K
497.4K
530.2K
249.0K
Employees
2.5
2
1.8
1.6
0.7

Frequently asked questions about ANTWERP PHARMACIES

  • Where is ANTWERP PHARMACIES located?

    ANTWERP PHARMACIES’s headquarters is located in N.B. de Borchgravestraat 4430 , 3800 Sint-Truiden.
  • When was ANTWERP PHARMACIES founded?

    ANTWERP PHARMACIES was founded in 2018-08-08. ANTWERP PHARMACIES has been active for 7 years.
  • What are ANTWERP PHARMACIES’s NACEBEL codes?

    ANTWERP PHARMACIES’s NACEBEL codes are
    • 47730 Commerce de produits pharmaceutiques (2025)
    • 47730 Commerce de détail de produits pharmaceutiques en magasin spécialisé (2008)
    • 64200 Activités des sociétés holding (2008)
    • 68100 Activités des marchands de biens immobiliers (2008)
    • 68201 Location et exploitation de biens immobiliers résidentiels propres ou loués, sauf logements sociaux (2008)
    • 70220 Conseil pour les affaires et autres conseils de gestion (2008)
  • What is ANTWERP PHARMACIES’s VAT number?

    ANTWERP PHARMACIES’s VAT number is BE0700733344.
  • What is ANTWERP PHARMACIES’s juridical form?

    ANTWERP PHARMACIES’s juridical type is Société à responsabilité limitée (SRL).
  • How many employees does ANTWERP PHARMACIES have?

    ANTWERP PHARMACIES has 2 employees.
  • How is the financial situation of ANTWERP PHARMACIES?

    openthebox has estimated that ANTWERP PHARMACIES’s financial health score to be 7/10.